HPV screen-and treat-intervention effective in cervical cancer prevention

	Tweet

Women in South Africa who underwent human papillomavirus (HPV) DNA-based testing or visual inspection of the cervix followed by treatment of test-positive women with cryotherapy had a statistically significant reduction in high grade cervical cancer precursors, compared with women in a control group, according to a study published online Sept. 30 in The Journal of the National Cancer Institute.

In many developing countries, especially in sub-Saharan Africa, cytology-based screening is unavailable. To counter this lack of availability, non-cytological screening methods such as DNA testing or visual inspection of the cervix have been developed, methods that do not require the same laboratory infrastructure as cytology and allow for the immediate treatment of women with detected lesions. The approach of screening using non-cytological methods and then treating all test positive women is referred to as “screen-and-treat” and access to such cervical cancer prevention programs may be able to reduce cervical cancer mortality where cytology-based screening is unavailable.

To determine whether HPV DNA-based screening and visual inspection of the cervix reduced cervical cancer, Thomas C. Wright, M.D., of Columbia University, and colleagues, conducted a randomized trial of 6637 unscreened South African women aged 35-56 years, who were assigned to three study arms: HPV DNA screen-and-treat, in which women with a positive HPV test, VIA screen-and-treat in which women with a positive visual inspection test underwent cryotherapy; or a control group, in which further evaluation and treatment were delayed for 6 months. 

The researchers tested the women for 36 months, and measured cervical cancer lesions of grade two or worse, also known as CIN 2+ for cervical intraepithelial neoplasia.

The researchers found that after 36 months of follow-up, the women who developed CIN2+ included 1.5% in the screen-and-treat arm, 3.8% in the visual inspection-and-treat arm, and 5.6% in the control arm. The authors write, “This study demonstrates that an HPV DNA-based screen-and-treat program for cervical cancer is highly effective and produces a durable reduction in CIN 2+.”

Furthermore, they write: “These results suggest that cryotherapy may have long-term implications for low-resource settings where it is difficult and costly to re-screen women at regular intervals.”

In an accompanying editorial, Julia C. Gage and Philip E. Castle of the National Cancer Institute write that the advent of accurate low-cost HPV DNA testing bodes well for women in low-income settings—provided political will and monetary investment accompany technological advancement. “With low-cost accurate HPV screening tests coming online, cervical cancer prevention is becoming more effective, affordable, and feasible for low-resource settings,” they write.

###

Contact: Kristine Crane

301-841-1285
Journal of the National Cancer Institute

RELATED STORIES:
Higher rates of cervical cancer amongst immigrants   Cervical cancer vaccines may cut need for screening   1-visit screening, prevention for cervical cancer holds promise   Cervical cancer survivors prone to other cancers   Urinary tract cancer associated with Chinese herbal products containing aristolochic acid   New MRI technique may identify cervical cancer early   Doctors say HPV vaccine should be given to everyone   Cervical cancer vaccine can protect men from HPV   Smoking increases risk cervical cancer   Vaccine no replacement for Pap test   Health panel cautious on HPV screening vs Pap   IUDs almost halve risk of cervical cancer: study   High cervical cancer rates sign of larger problems   Merck cervical cancer shot gives 5-year protection   Women with AIDS face cervical cancer threat   Newly Created Cancer Stem Cells Could Aid Breast Cancer Research   Gates cash backs cervical cancer shots for poor   US FDA approves Hycamtin for cervical cancer   FDA approval of Gardasil to prevent cervical cancer   Health Groups Issue Cervical Cancer Screening Guidelines   Teen Vaccinations against Cervical Cancer Lagging   Screening for cervical cancer low for immigrant women

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]